Hydroxychloroquine for the Treatment of Mild COVID-19 Disease

NCT04340544 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class

Stopped It appeared to be impossible for the study centres to recruit the targeted number of patients, due to reduced incidence and reduced acceptance to IMP

Conditions

Interventions

Sponsor

University Hospital Tuebingen

Collaborators